Cary Pfeffer

Cary led Third Rock’s partner development efforts to build and maintain strong relationships with R&D and business executives of most major biotech and pharmaceutical companies in order to enhance our portfolio companies’ efforts to enter collaborations with them. In addition to leading multiple portfolio companies as CBO or CEO when they launch, Cary played an instrumental role in a number of innovative alliances across our portfolio, including an industry-leading global strategic collaboration between Agios and Celgene in the field of cancer metabolism.